Want to see CVRX full AI Analyst Report?

CVRx (CVRX) Stock Forecast & Price Target

204 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CVRX Analyst Ratings

Moderate Buy

3 Buy

3 Hold

0 Sell

Based on 6 analysts giving stock ratings to

CVRx

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CVRX Stock 12 Month Forecast

Average Price Target

$4.38

▼(-7.70% Downside)

Based on 6 Wall Street analysts offering 12 month price targets for CVRx in the last 3 months. The average price target is $4.38 with a high forecast of $5.00 and a low forecast of $3.50. The average price target represents a -7.70% change from the last price of $4.74.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","11":"$11","4.25":"$4.25","6.5":"$6.5","8.75":"$8.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$5.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.375,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$4.38</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,4.25,6.5,8.75,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.175,5.161538461538461,5.148076923076923,5.134615384615384,5.121153846153846,5.107692307692307,5.094230769230769,5.0807692307692305,5.0673076923076925,5.053846153846154,5.040384615384616,5.026923076923077,5.013461538461539,{"y":5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.175,5.1134615384615385,5.051923076923077,4.990384615384615,4.928846153846154,4.867307692307692,4.805769230769231,4.744230769230769,4.6826923076923075,4.621153846153846,4.559615384615385,4.498076923076923,4.436538461538461,{"y":4.375,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.175,5.046153846153846,4.917307692307692,4.788461538461538,4.6596153846153845,4.530769230769231,4.401923076923077,4.273076923076923,4.144230769230769,4.015384615384615,3.8865384615384615,3.7576923076923077,3.628846153846154,{"y":3.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.56,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.73,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.96,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.19,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.4,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.1,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.12,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.22,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.1,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.97,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.43,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.5,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.175,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$5.00

Average Price Target$4.38

Lowest Price Target$3.50

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Sarah James

Cantor Fitzgerald

$13→$5

Buy

5.49%

Upside

Reiterated

08/17/26

CVRx price target lowered to $5 from $13 at Cantor FitzgeraldCVRx price target lowered to $5 from $13 at Cantor Fitzgerald

Chase Knickerbocker

Craig-Hallum

―

Hold

―

Reiterated

08/11/26

Analysts Conflicted on These Healthcare Names: CVRx (NASDAQ: CVRX), Jazz Pharmaceuticals (NASDAQ: JAZZ) and Disc Medicine (NASDAQ: IRON)

William Plovanic

Canaccord Genuity

Buy

5.49%

Upside

Reiterated

08/11/26

Analyst Reaffirms Buy on CVRx, Maintains Unchanged $5 Price Target Amid Improving Reimbursement and Growth Outlook

Frank Takkinen

Lake Street

$14→$3.5

Hold

-26.16%

Downside

Downgraded

08/07/26

CVRx downgraded to Hold from Buy at Lake StreetCVRx downgraded to Hold from Buy at Lake Street

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

08/07/26

Analysts Offer Insights on Healthcare Companies: CVRx (NASDAQ: CVRX) and Solid Biosciences (NASDAQ: SLDB)

Matthew O'Brien

Piper Sandler

$12→$4

Hold

-15.61%

Downside

Downgraded

08/07/26

O'Brien Maintains Hold on CVRx, Cuts Price Target from $12 to $4 Amid Execution Challenges and Trimmed Outlook

Robbie Marcus

J.P. Morgan

Sell

26.58%

Upside

Reiterated

05/12/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: West Pharmaceutical Services (NYSE: WST), CVRx (NASDAQ: CVRX) and AbCellera Biologics (NASDAQ: ABCL)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Sarah James

Cantor Fitzgerald

$13→$5

Buy

5.49%

Upside

Reiterated

08/17/26

CVRx price target lowered to $5 from $13 at Cantor FitzgeraldCVRx price target lowered to $5 from $13 at Cantor Fitzgerald

Chase Knickerbocker

Craig-Hallum

―

Hold

―

Reiterated

08/11/26

Analysts Conflicted on These Healthcare Names: CVRx (NASDAQ: CVRX), Jazz Pharmaceuticals (NASDAQ: JAZZ) and Disc Medicine (NASDAQ: IRON)

William Plovanic

Canaccord Genuity

Buy

5.49%

Upside

Reiterated

08/11/26

Analyst Reaffirms Buy on CVRx, Maintains Unchanged $5 Price Target Amid Improving Reimbursement and Growth Outlook

Frank Takkinen

Lake Street

$14→$3.5

Hold

-26.16%

Downside

Downgraded

08/07/26

CVRx downgraded to Hold from Buy at Lake StreetCVRx downgraded to Hold from Buy at Lake Street

Brandon Vazquez

William Blair

―

Buy

―

Reiterated

08/07/26

Analysts Offer Insights on Healthcare Companies: CVRx (NASDAQ: CVRX) and Solid Biosciences (NASDAQ: SLDB)

Matthew O'Brien

Piper Sandler

$12→$4

Hold

-15.61%

Downside

Downgraded

08/07/26

O'Brien Maintains Hold on CVRx, Cuts Price Target from $12 to $4 Amid Execution Challenges and Trimmed Outlook

Robbie Marcus

J.P. Morgan

Sell

26.58%

Upside

Reiterated

05/12/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: West Pharmaceutical Services (NYSE: WST), CVRx (NASDAQ: CVRX) and AbCellera Biologics (NASDAQ: ABCL)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

IMMXImmix Biopharma

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CVRx

3 Months

William PlovanicCanaccord Genuity

Success Rate

12/28 ratings generated profit

Average Return

-0.20%

Copying William Plovanic's trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of -0.20% per trade.

1 Year

Robbie MarcusJ.P. Morgan

Success Rate

8/14 ratings generated profit

Average Return

+12.16%

Copying Robbie Marcus's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +12.16% per trade.

2 Years

Robbie MarcusJ.P. Morgan

Success Rate

5/14 ratings generated profit

Average Return

+12.74%

Copying Robbie Marcus's trades and holding each position for 2 Years would result in 35.71% of your transactions generating a profit, with an average return of +12.74% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CVRX Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CVRX has received 10 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. CVRX average Analyst price target in the past 3 months is 4.38.

Each month's total comprises the sum of three months' worth of ratings.

CVRX Financial Forecast

CVRX Earnings Forecast

Next quarter’s earnings estimate for CVRX is -$0.49 with a range of -$0.53 to -$0.47. The previous quarter’s EPS was -$0.53. CVRX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CVRX has Performed in-line its overall industry.

CVRX Sales Forecast

Next quarter’s sales forecast for CVRX is $13.94M with a range of $13.50M to $14.20M. The previous quarter’s sales results were $15.71M. CVRX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CVRX has Performed in-line its overall industry.

CVRX Stock Forecast FAQ

What is CVRX’s average 12-month price target, according to analysts?

Based on analyst ratings, CVRx’s 12-month average price target is 4.38.

What is CVRX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CVRX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CVRX a Buy, Sell or Hold?

CVRx has a consensus rating of Moderate Buy which is based on 3 buy ratings, 3 hold ratings and 0 sell ratings.

What is CVRx’s price target?

The average price target for CVRx is 4.38. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $5.00 ,the lowest forecast is $3.50. The average price target represents -7.70% Decrease from the current price of $4.74.

What do analysts say about CVRx?

CVRx’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of CVRX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

CVRx (CVRX) Stock Forecast & Price Target

CVRX Analyst Ratings

CVRX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering CVRx

CVRX Analyst Recommendation Trends

CVRX Financial Forecast

CVRX Earnings Forecast

CVRX Sales Forecast

CVRX Stock Forecast FAQ

Detailed List of Analyst Forecasts